Covid-19 Guidance

Smart, innovative, digital: where progressive pharma companies achieve ambitious new objectives

Attend the event where Commercial, Medical, RWE and Clinical transformation will be determined

Back for it’s 13th year: eyeforpharma Japan 2020 is where you will decide your future. The healthcare landscape is evolving and pharma must evolve with it. That’s why we have ensured that our agenda features great insights on how to achieve high effectiveness with limited time and resources. Sometimes this involves digitizing existing processes, sometimes it involves forming new partnerships and sometimes it requires imaginative new business models. We will also provide great case studies from industry leaders and plenty of networking time.

From the Opening Keynote, focusing on future direction of pharma with cutting-edge case studies, to the practical tracks covering Digital Clinical Innovation, Commercial Excellence, Medical Affairs & RWE, we will deliver a new direction for your planning.

Be part of the movement to evolve Japan’s pharma industry!

eyeforpharma Japan is a valuable platform for our industry to network, exchange views and anticipate our industry trends and evolution.

Alexandre de Muralt, Representative Director and President, Merck Biopharma Co., Ltd. Merck  Logo Alexandre de Muralt Headshot

Secure your place at the event by Friday, 3rd April!

Get free access to slides and audio of Digital & Marketing session (key insights from 20+ commercial experts from Europe’s premier pharma conference with world-class speakers, Worth 60,000 JPY), if you register for eyeforpharma Japan by Friday, 3rd April.

New speakers confirmed:

Hiroshi Sugii - Headshot
Novo Nordisk Pharma Ltd - Logo

Hiroshi Sugii Manager Director/Member of the Board of Directors, Corporate Vice President, CMR Development Division Novo Nordisk Pharma Ltd

Keisuke Yoshimura, MD. MPH, PhD - Headshot
Center for Next Generation of Community Health Chiba University Hospital - Logo

Keisuke Yoshimura, MD. MPH, PhD Specially Appointed Professor and Director Center for Next Generation of Community Health Chiba University Hospital

Taro Goto, M.D., Ph.D. - Headshot
Bristol-Myers-Squibb KK - Logo

Taro Goto, M.D., Ph.D. Executive officer, Head of Medical and Head of R&D (interim) Bristol-Myers-Squibb KK


Susumu Kitamura - Headshot
AbbVie GK - Logo

Susumu Kitamura Director, Head of Regulatory Affairs Japan AbbVie GK

Yuta Watanabe - Headshot
Astellas Pharma Inc. - Logo

Yuta Watanabe Rx+ Business Accelerator Astellas Pharma Inc.

Jim Crompton - Headshot
Janssen Pharmaceutical K.K. - Logo

Jim Crompton Director Regional Market Access Policy Market Access, Asia Pacific Janssen Pharmaceutical K.K.

World-class speaker faculty in includes:
(65% coming from Top 50 pharma in Japan)

Taro Ueno - Headshot
SUSMED Inc. - Logo

Taro Ueno CEO SUSMED Inc.

Stefan Sakurai - Headshot
LEO Pharma - Logo

Stefan Sakurai President / Japan Representative Director LEO Pharma


Masatsune Okajima - Headshot
StemRIM - Logo

Masatsune Okajima President and COO StemRIM

Hiroyuki Yoshihara - Headshot
Life Data Initiative, Japan - Logo

Hiroyuki Yoshihara Representative Director Life Data Initiative, Japan Emeritus Professor Kyoto University and University of Miyazaki, Japan


Eiji Aramaki - Headshot
NAIST Graduate School of Science and Technology - Logo

Eiji Aramaki Associate Professor, PI, Information Science NAIST Graduate School of Science and Technology

Jovelle L. Fernandez - Headshot
Takeda - Logo

Jovelle L. Fernandez Head Japan Medical Office Takeda

Susie Barnes - Headshot
GlaxoSmithKline Japan - Logo

Susie Barnes Vice President and Country Medical Director GlaxoSmithKline Japan

Kentaro Kume - Headshot
Takeda Pharmaceutical Company Limited - Logo

Kentaro Kume Head, R&D Partnership Office Asia Pacific Takeda Pharmaceutical Company Limited


David Hernandez - Headshot
Merck Biopharma Co., Ltd. - Logo

David Hernandez Head of Clinical Operations Japan, Global Clinical Operations Merck Biopharma Co., Ltd.

Haider Alleg - Headshot
Ferring Pharmaceuticals - Logo

Haider Alleg Global Head of Digital Excellence Ferring Pharmaceuticals


Debraj Dasgupta - Headshot
Nippon Boehringer Ingelheim Co., Ltd. - Logo

Debraj Dasgupta Operating Officer, Head of Strategy and GTM Planning Division Nippon Boehringer Ingelheim Co., Ltd.

Naohiro Yonemoto - Headshot
Pfizer - Logo

Naohiro Yonemoto Director, Patient Impact Analysis, Outcome & Evidence,
Corporate affairs, Health & Value
Pfizer

4 essential themes for 2020

Digital transformation: Transform your business model by ensuring you act decisively on customer insights. Recognize the need to digitize. Focus on value with partnerships that deliver holistic patient outcomes.

Evidence-led leadership: Generate great evidence through data. Ensure its communicated well to improve decision-making, portfolio design, patient recruitment and better, medically-driven content.

Deliver patient value to drive commercial & medical excellence: Prove the authenticity of your medicine and care provision with robust data and a great story for HCPs and patient outcomes.

Make Japan a clinical powerhouse: See how data and digital technology can cut costs and time in clinical development. Drive a more patient-centric approach in development to ensure Japan becomes the world's best place to run innovative clinical trials.

eyeforpharma is always at the forefront of the pharma industry’s next movement.

Katsunori Ohyama, Director, Severe asthma dedicated sales force, GlaxoSmithKline K.K. Headshot

Delivered through 4 business-critical tracks

Keynote Get out of your comfort zone and explore the new frontiers of medicine from the ‘digital twin’ to advanced genomics, digital therapeutics, AI and more.

Learn more about this track

Commercial Excellence A new commercial model is needed to effectively deliver digital transformation. Use technology to provide deeper value to physicians and even patients.

Learn more about this track


RWE & Medical: Make trust your most important principle by communicating in an authentic, scientific way, backed by evidence. Use RWE to speed development, widen access and boost patient outcomes.

Learn more about this track

Digital Clinical Innovation: Cut time and cost through new technology, whilst enabling a more patient-centric approach which boosts recruitment and retention. Recognize that smarter clinical trials could unlock a golden era for pharma.

Learn more about this track

Key features of eyeforpharma Japan

4 business-critical conference streams

eyeforpharma Japan will cover all key topics with four tracks: Keynote, Digital Clinical Innovation, RWE & Medical and Commercial Excellence. Which means you’ll gain insights which will help drive your business.

Networking

Network with attendees in 15+ hours of dedicated networking time, networking events and interactive sessions.

All stakeholders. All functions. 1 Place.

The most cross-functional pharma event in Japan – decision-makers from marketing, commercial, sales, market access, medical affairs, patient engagement, RWE, digital transformation, IT, clinical and more.


The most senior-level pharma event in Japan

You won’t find a better place to meet your peers since over 80% of the pharma attendees are director-level or above.

Find the solution

Sometimes, the best ideas don’t come from the stage. They come from those chance happenings when you join a roundtable or attend a networking evening. eyeforpharma is packed with opportunities for you to connect with prospective collaborators and idea generators.

Drive the future

Experts and thought leaders will share cutting edged case studies. Re-position your strategy and teams aligned to the industry’s next movement.


eyeforpharma Japan is a useful platform to be informed about recent trends in pharma industry.

Jovelle L. Fernandez, MD, PhD, FPOGS, Head, Japan Medical Office, Takeda Pharmaceutical Company Headshot

An action-packed timetable

Attended by pharma and health innovators from:

bayer's Logo
allergan's Logo
EFPIA's Logo
bms's Logo

astra_zeneca's Logo
Daiichi Sankyo's Logo

gilead's Logo
novo_nordisk's Logo

kyoto_university's Logo
johnson_johnson's Logo

boehringer_ingelheim's Logo
sandoz's Logo


chugai_no_roche's Logo
merck_darkerblue's Logo
shionogi's Logo
Eisai's Logo

roche's Logo
amicus's Logo

pfizer's Logo
takeda's Logo


university_of_tokyo's Logo
biogen's Logo
transcelerate's Logo
ViiV Healthcare's Logo


otsuka_us's Logo
janssen's Logo
nestle's Logo
sanofi's Logo

lilly's Logo
tokyo_medical_and_dental_university's Logo


gsk_logo's Logo
novartis's Logo

UCB's Logo
LEO Pharma's Logo
amed's Logo
astellas_amgen_biopharma's Logo


csl's Logo
msd's Logo
astellas's Logo
abbvie's Logo


You won’t find your next idea at home. Make the most of the networking with:

10+ hours
of networking

Total interaction Roundtables, workshops and panel discussions

Real decision-makers

Other events say they attract senior executives - people with clout, budget, ideas and a mission. We really mean it.

77% of attendees are director-level and above

Real diversity

eyeforpharma Japan attracts a variety of job titles, geographies, cultures and opinions create a rich tapestry.

Here to help

Get in touch with the eyeforpharma team

Paul Simms Headshot

Paul Simms Chairman

Blair Gottscho Headshot

Blair Gottscho VP Operations


Kana Chia Headshot

Kana Chia Head of Japan


Hiromasa Araki Headshot

Hiromasa Araki Business Development Executive, Japan



Itsumi Nishikawa Headshot

Itsumi Nishikawa Project Director

Akari Ueda Headshot

Akari Ueda Project Director, Japan



Ross McMullan Headshot

Ross McMullan Business Development Director